A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that afflicts ...
A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more ...
Many drugs, such as monoclonal antibodies and ... remain important for IFDs such as mucormycosis. In 1981, the first azole antifungal, the diazole ketoconazole, was introduced to the market ...
A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more ...
Scientists have identified strains of one of the world’s most dangerous fungal pathogens, already resistant to our most ...
The efficacy and safety of a combination therapy including caspofungin and another antifungal (either AMB or an azole) in a small ... without a major concern about drug-related side effects.